Clinical Trial Update: Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 500mg and Rosuvastatin 10mg [Phase 1]

View source ↗

Summary

Phase 1 study comparing pharmacokinetics of HCP1201 alone versus co-administration with metformin SR 500mg and rosuvastatin 10mg in diabetes mellitus; study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• HCP1201
• Metformin SR 500mg (metformin sustained-release)
• Rosuvastatin 10mg (rosuvastatin)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Diabetes Mellitus | Phase 1 | Status: COMPLETED